|
MORF4L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.849900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.577240E-01 |
| Normal-vs-Stage2 |
1.641960E-01 |
| Normal-vs-Stage3 |
1.860040E-01 |
| Normal-vs-Stage4 |
3.430400E-02 |
| Stage1-vs-Stage2 |
5.855200E-01 |
| Stage1-vs-Stage3 |
8.294800E-01 |
| Stage1-vs-Stage4 |
1.569420E-01 |
| Stage2-vs-Stage3 |
8.028600E-01 |
| Stage2-vs-Stage4 |
3.995800E-01 |
| Stage3-vs-Stage4 |
2.545600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.072500E-02 |
| Normal-vs-AfricanAmerican |
5.084800E-01 |
| Normal-vs-Asian |
9.710200E-01 |
| Caucasian-vs-AfricanAmerican |
4.796200E-03 |
| Caucasian-vs-Asian |
5.657400E-01 |
| AfricanAmerican-vs-Asian |
7.417400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.627900E-02 |
| Normal-vs-Female |
1.968360E-02 |
| Male-vs-Female |
3.905400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.169400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.654100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.026190E-01 |
| Normal-vs-Age(81-100Yrs) |
5.389400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.791200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.716400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.492800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.244000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.687000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.985400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.050600E-01 |
| Normal-vs-Grade 2 |
1.998250E-02 |
| Normal-vs-Grade 3 |
1.525970E-01 |
| Normal-vs-Grade 4 |
1.967200E-01 |
| Grade 1-vs-Grade 2 |
8.078000E-01 |
| Grade 1-vs-Grade 3 |
7.384000E-01 |
| Grade 1-vs-Grade 4 |
8.147800E-01 |
| Grade 2-vs-Grade 3 |
3.169200E-01 |
| Grade 2-vs-Grade 4 |
9.319400E-01 |
| Grade 3-vs-Grade 4 |
5.847200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.898100E-03 |
| Normal-vs-ccB subtype |
3.185200E-01 |
| ccA subtype-vs-ccB subtype |
1.085820E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.893900E-02 |
| Normal-vs-N1 |
8.160000E-01 |
| N0-vs-N1 |
5.992400E-01 |
|
|
